O
DCPH
OrbiMed’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,183,143
| Closed | -$74.2M | – | 176 |
|
|
2021
Q3 | $74.2M | Sell |
2,183,143
-1,114,158
| -34% | -$37.9M | 0.82% | 38 |
|
|
2021
Q2 | $121M | Buy |
3,297,301
+1,916,401
| +139% | +$70.2M | 1.22% | 26 |
|
|
2021
Q1 | $61.9M | Buy |
1,380,900
+255,200
| +23% | +$11.4M | 0.58% | 49 |
|
|
2020
Q4 | $64.2M | Hold |
1,125,700
| – | – | 0.56% | 51 |
|
|
2020
Q3 | $57.7M | Hold |
1,125,700
| – | – | 0.73% | 39 |
|
|
2020
Q2 | $67.2M | Sell |
1,125,700
-31,900
| -3% | -$1.91M | 0.95% | 32 |
|
|
2020
Q1 | $47.7M | Sell |
1,157,600
-356,571
| -24% | -$14.7M | 0.8% | 39 |
|
|
2019
Q4 | $94.2M | Sell |
1,514,171
-946,400
| -38% | -$58.9M | 1.35% | 28 |
|
|
2019
Q3 | $83.5M | Sell |
2,460,571
-1,157,600
| -32% | -$39.3M | 1.58% | 21 |
|
|
2019
Q2 | $81.6M | Hold |
3,618,171
| – | – | 1.26% | 25 |
|
|
2019
Q1 | $84M | Buy |
3,618,171
+1,175,971
| +48% | +$27.3M | 1.3% | 22 |
|
|
2018
Q4 | $51.3M | Buy |
2,442,200
+488,700
| +25% | +$10.3M | 0.95% | 35 |
|
|
2018
Q3 | $75.6M | Sell |
1,953,500
-52,200
| -3% | -$2.02M | 0.91% | 31 |
|
|
2018
Q2 | $78.9M | Buy |
2,005,700
+472,800
| +31% | +$18.6M | 0.94% | 36 |
|
|
2018
Q1 | $30.7M | Buy |
1,532,900
+356,830
| +30% | +$7.15M | 0.38% | 67 |
|
|
2017
Q4 | $26.7M | Buy |
1,176,070
+781,800
| +198% | +$17.7M | 0.34% | 70 |
|
|
2017
Q3 | $7.49M | Buy |
+394,270
| New | +$7.49M | 0.07% | 108 |
|